GGrantIndex
Sort

39,280 grants matching leukemia

Lenalidomide Treatment and the Chronic Lymphocytic Leukemia Microenvironment

$339,900
Thomas J. Kipps · University Of California, San Diego · R21 · FY2010 · CA

Engineered T Cell Therapy for Melanoma

$339,874
Robert H Vonderheide · Wistar Institute · P50 · FY2016 · CA

ELECTRON SPIN RELAXATION IN MODEL MEMBRANES

$339,859
Cornell University Ithaca · R01 · FY2000 · GM

Presenilins in tumorigenesis and neurodegeneration

$339,853
Hui Zheng · Baylor College Of Medicine · R01 · FY2006 · NS

RNA Splicing Modulators for MDS/AML

$339,822
Timothy A Graubert · Washington University · P50 · FY2013 · CA

CCR5 Analyses in HIV Infected Hematology Patients undergoing Umbilical Cord Blood Allogeneic Transplantation

$339,820
Filippo Milano · Fred Hutchinson Cancer Research Center · R34 · FY2018 · HL

Signaling Pathway in Ah Receptor-Dependent Control of Hematopoietic Stem Cells

$339,768
Thomas A Gasiewicz · University Of Rochester · R01 · FY2013 · ES

CELLULAR RETINOIC ACID BINDING PROTEIN--FUNCTIONAL STUDI

$339,753
Weill Medical College Of Cornell Univ · R01 · FY2002 · CA

viruses for gene-trap/misexpression screens in Zebrafish

$339,750
Oregon Health And Science University · R01 · FY2004 · EY

Genes Controlling Blood Cell Development in Drosophila

$339,750
University Of Texas Md Anderson Can Ctr · R01 · FY2003 · HL

viruses for gene-trap and misexpression screens

$339,750
Oregon Health And Science University · R01 · FY2005 · EY

PROTEIN KINASE C ISOTYPES IN LEUKEMIA CELL PHYSIOLOGY

$339,747
University Of Texas Medical Br Galveston · R01 · FY2002 · CA

Animal Modeling and Clinical Resources Core

$339,719
David F Claxton · Pennsylvania State Univ Hershey Med Ctr · P01 · FY2014 · CA

Role of DOK family proteins in lung tumor suppression

$339,713
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2014 · CA

CLINCIAL VALIDATION OF APC AND TP53 AS BIOMARKERS FOR CETUXIMAB RESPONSE

$339,695
Timothy J Yeatman · University Of Utah · UH2 · FY2019 · CA

SON-mediated gene expression and leukemia

$339,694
Erin Eun-Young Ahn · University Of Alabama At Birmingham · R01 · FY2021 · CA

Molecular Genetics of Segment Identity

$339,641
Richard S Mann · Columbia University Health Sciences · R01 · FY2007 · GM

RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment

$339,529
Jiwang Zhang · Loyola University Chicago · R01 · FY2018 · CA

RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment

$339,529
Jiwang Zhang · Loyola University Chicago · R01 · FY2020 · CA

RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment

$339,529
Jiwang Zhang · Loyola University Chicago · R01 · FY2021 · CA

The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia

$339,487
Jessica S. Blackburn · University Of Kentucky · R37 · FY2019 · CA

Intranasal LIF to improve neurological recovery from perinatal hypoxia-ischema

$339,472
Steven W Levison · Rbhs-New Jersey Medical School · R01 · FY2022 · NS

Intranasal LIF to improve neurological recovery from perinatal hypoxia-ischema

$339,472
Steven W Levison · Rutgers Biomedical And Health Sciences · R01 · FY2023 · NS

Genomics of Familial MDS/AML

$339,464
Timothy A Graubert · Washington University · P01 · FY2017 · CA

Molecular and Cellular Characterization of Myeloprolife*

$339,457
Kathleen Miho Sakamoto · University Of California Los Angeles · R01 · FY2006 · HL